127 related articles for article (PubMed ID: 32748441)
1. An infant with ETV6-NTRK3 fusion-positive congenital infantile fibrosarcoma and delayed response to conventional chemotherapy avoiding the need for TRK inhibition.
Vedi A; Holland K; Cross J; Muthusamy B; Behjati S; Hook CE; Murray MJ
Pediatr Blood Cancer; 2020 Oct; 67(10):e28628. PubMed ID: 32748441
[No Abstract] [Full Text] [Related]
2. Rapid, complete and sustained tumour response to the TRK inhibitor larotrectinib in an infant with recurrent, chemotherapy-refractory infantile fibrosarcoma carrying the characteristic ETV6-NTRK3 gene fusion.
Bielack SS; Cox MC; Nathrath M; Apel K; Blattmann C; Holl T; Jenewein R; Klenk U; Klothaki P; Müller-Abt P; Ortega-Lawerenz S; Reynolds M; Scheer M; Simon-Klingenstein K; Stegmaier S; Tupper R; Vokuhl C; von Kalle T
Ann Oncol; 2019 Nov; 30 Suppl 8():viii31-viii35. PubMed ID: 32223937
[TBL] [Abstract][Full Text] [Related]
3. Rapid, complete and sustained tumour response to the TRK inhibitor larotrectinib in an infant with recurrent, chemotherapy-refractory infantile fibrosarcoma carrying the characteristic ETV6-NTRK3 gene fusion.
Bielack SS; Cox MC; Nathrath M; Apel K; Blattmann C; Holl T; Jenewein R; Klenk U; Klothaki P; Müller-Abt P; Ortega-Lawerenz S; Reynolds M; Scheer M; Simon-Klingenstein K; Stegmaier S; Tupper R; Vokuhl C; von Kalle T
Ann Oncol; 2019 Nov; 30(Suppl_8):viii31-viii35. PubMed ID: 31738425
[TBL] [Abstract][Full Text] [Related]
4. Role of chemotherapy in the treatment of infantile fibrosarcoma.
Shetty AK; Yu LC; Gardner RV; Warrier RP
Med Pediatr Oncol; 1999 Oct; 33(4):425-7. PubMed ID: 10491560
[No Abstract] [Full Text] [Related]
5. Congenital-infantile fibrosarcoma of the foot--avoidance of amputation.
Nason GJ; Baker JF; Seoighe D; Irvine AD; McDermott M; Orr D; Capra M; Kelly PM
Ir Med J; 2014 May; 107(5):148-9. PubMed ID: 24908860
[TBL] [Abstract][Full Text] [Related]
6. The role of preoperative chemotherapy in the treatment of infantile fibrosarcoma.
Kurkchubasche AG; Halvorson EG; Forman EN; Terek RM; Ferguson WS
J Pediatr Surg; 2000 Jun; 35(6):880-3. PubMed ID: 10873030
[TBL] [Abstract][Full Text] [Related]
7. Infantile fibrosarcoma. Report of a case with long-term follow-up.
Robinson W; Crawford AH
J Bone Joint Surg Am; 1990 Feb; 72(2):291-4. PubMed ID: 2303517
[No Abstract] [Full Text] [Related]
8. Congenital fibrosarcoma. Preoperative chemotherapy and conservative surgery.
Ninane J; Gosseye S; Panteon E; Claus D; Rombouts JJ; Cornu G
Cancer; 1986 Oct; 58(7):1400-6. PubMed ID: 3755646
[TBL] [Abstract][Full Text] [Related]
9. Clinicopathological findings of pediatric NTRK fusion mesenchymal tumors.
Kang J; Park JW; Won JK; Bae JM; Koh J; Yim J; Yun H; Kim SK; Choi JY; Kang HJ; Kim WS; Shin JH; Park SH
Diagn Pathol; 2020 Sep; 15(1):114. PubMed ID: 32957984
[TBL] [Abstract][Full Text] [Related]
10. Recurrent EML4-NTRK3 fusions in infantile fibrosarcoma and congenital mesoblastic nephroma suggest a revised testing strategy.
Church AJ; Calicchio ML; Nardi V; Skalova A; Pinto A; Dillon DA; Gomez-Fernandez CR; Manoj N; Haimes JD; Stahl JA; Dela Cruz FS; Tannenbaum-Dvir S; Glade-Bender JL; Kung AL; DuBois SG; Kozakewich HP; Janeway KA; Perez-Atayde AR; Harris MH
Mod Pathol; 2018 Mar; 31(3):463-473. PubMed ID: 29099503
[TBL] [Abstract][Full Text] [Related]
11. Chemotherapy in the management of infantile fibrosarcoma.
Kynaston JA; Malcolm AJ; Craft AW; Davies SM; Jones PH; King DJ; Mitchell CD; Oakhill A; Stiller CA
Med Pediatr Oncol; 1993; 21(7):488-93. PubMed ID: 8341216
[TBL] [Abstract][Full Text] [Related]
12. Infantile Fibrosarcoma With NTRK3-ETV6 Fusion Successfully Treated With the Tropomyosin-Related Kinase Inhibitor LOXO-101.
Nagasubramanian R; Wei J; Gordon P; Rastatter JC; Cox MC; Pappo A
Pediatr Blood Cancer; 2016 Aug; 63(8):1468-70. PubMed ID: 27093299
[TBL] [Abstract][Full Text] [Related]
13. Infantile fibrosarcoma: clinical and histologic responses to cytotoxic chemotherapy.
Russell H; Hicks MJ; Bertuch AA; Chintagumpala M
Pediatr Blood Cancer; 2009 Jul; 53(1):23-7. PubMed ID: 19340853
[TBL] [Abstract][Full Text] [Related]
14. Infantile fibrosarcoma-like tumor driven by novel
Gupta A; Belsky JA; Schieffer KM; Leraas K; Varga E; McGrath SD; Koo SC; Magrini V; Wilson RK; White P; Mardis ER; Jatana KR; Cottrell CE; Setty BA
Cold Spring Harb Mol Case Stud; 2020 Oct; 6(5):. PubMed ID: 33028644
[TBL] [Abstract][Full Text] [Related]
15. Chemotherapy alone for the treatment of congenital fibrosarcoma: is surgery always needed?
Surico G; Muggeo P; Daniele RM; Novielli C; Rigillo N; Minervini C
Med Pediatr Oncol; 2003 Apr; 40(4):268-70. PubMed ID: 12555264
[No Abstract] [Full Text] [Related]
16. Infantile fibrosarcoma treated with postoperative vincristine and dactinomycin.
Yoshihara H; Yoshimoto Y; Hosoya Y; Hasegawa D; Kawano T; Sakoda A; Okita H; Manabe A
Pediatr Int; 2017 Mar; 59(3):371-374. PubMed ID: 28317309
[TBL] [Abstract][Full Text] [Related]
17. Conservative strategy in infantile fibrosarcoma is possible: The European paediatric Soft tissue sarcoma Study Group experience.
Orbach D; Brennan B; De Paoli A; Gallego S; Mudry P; Francotte N; van Noesel M; Kelsey A; Alaggio R; Ranchère D; De Salvo GL; Casanova M; Bergeron C; Merks JH; Jenney M; Stevens MC; Bisogno G; Ferrari A
Eur J Cancer; 2016 Apr; 57():1-9. PubMed ID: 26849118
[TBL] [Abstract][Full Text] [Related]
18. Infantile fibrosarcoma: retrospective analysis of eleven patients.
Akyüz C; Küpeli S; Varan A; Gedikoglu G; Yalçin B; Kutluk T; Büyükpamukçu M
Tumori; 2011; 97(2):166-9. PubMed ID: 21617710
[TBL] [Abstract][Full Text] [Related]
19. Second Report of
Hughes CE; Correa H; Benedetti DJ; Smith B; Sumegi J; Bridge J
Pediatr Dev Pathol; 2021; 24(6):554-558. PubMed ID: 34120511
[TBL] [Abstract][Full Text] [Related]
20. Therapeutic strategies and clinical evolution of patients with infantile fibrosarcoma: a unique paediatric case series.
Corral Sánchez MD; Jiménez Carrascoso R; Rubio Aparicio P; Plaza López de Sabando D; Sastre Urgelles A; Pozo-Kreilinger JJ; López Gutiérrez JC; Gómez Cervantes M; Ortiz Cruz EJ; Pérez-Martínez A
Clin Transl Oncol; 2023 Nov; 25(11):3307-3311. PubMed ID: 37097530
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
